AbCellera Biologics Inc. (ABCL)
NASDAQ·Healthcare·Biotechnology
$11.87
+0.34%
Mkt Cap $3.98B
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (12 analysts)
$14.75
Range $7.00 – $30.00
Implied Upside
+24.3%
Consensus $14.75 vs current $11.87
NASDAQ·Healthcare·Biotechnology
$11.87
+0.34%
Mkt Cap $3.98B
Buy
4
Hold
0
Sell
0
Price Target (12 analysts)
$14.75
Range $7.00 – $30.00
+24.3%
Consensus $14.75 vs current $11.87